A pilot study on the comparative minimum inhibitory and mutant prevention concentration values for moxifloxacin and pradofloxacin against canine and human isolates of Staphylococcus pseudintermedius and S. schleiferi.

CONCLUSIONS AND CLINICAL IMPORTANCE: The narrow MSW of these drugs may reduce the risk of selecting for antibiotic-resistant subpopulations. Pharmacokinetic, pharmacodynamic and safety studies are needed. PMID: 31486554 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31486554?dopt=Abstract

Source: Veterinary Dermatology - September 4, 2019 Category: Veterinary Research Authors: Plowgian C, Blondeau JM, Levinson M, Rosenkrantz W Tags: Vet Dermatol Source Type: research